Skip to Main Content

Funding Opportunities

Research Supplements to Promote Re-entry and Re-integration Into Health-Related Research Careers

For investigators developing independent research careers this supplement will provide up to and no more than $100,000/year for salary, plus fringe benefits. Prospective applicants and their mentors are strongly encouraged to contact their respective NCATS program officer and/or the scientific contact listed in this opportunity during the initial preparation of a supplement application and prior to its submission to discuss the goals and objectives of the supplement application.

Application Deadline: November 1, 2021



This award has been established to support the development and diversity of highly talented cancer researchers from underrepresented groups (as per NIH guidelines) in the field of clinical cancer research.

Application Deadline: November 30, 2021


Established to support the development of highly talented cancer researchers from under-represented groups (as per NIH guidelines). Eligibility is limited to members of racial or ethnic groups that have been shown to be underrepresented in the cancer related sciences.

Application Deadline: November 30, 2021



These awards represent a focused effort to encourage and support investigators from diverse backgrounds traditionally excluded in cancer research and to foster their career advancement. This grants program also intends to build a more diverse and inclusive future for breast cancer research.

Application Deadline: November 30, 2021



HHMI seeks to increase diversity in the biomedical research community. The goal of the Hanna H. Gray Fellows Program is to recruit and retain individuals from gender, racial, ethnic, and other groups underrepresented in the life sciences, including those individuals from disadvantaged backgrounds.

Application Deadline: December 1, 2021


Provides flexible funding to outstanding researchers who have made, and are continuing to make, significant contributions in breast cancer research and will dedicate their time in training future breast cancer researchers.

Letter of Intent Due: December 14, 2021


Designed with the primary goal of increasing diversity in the oncology workforce and cancer research. Awards will be given to mid-career investigators who are members of racial and/or ethnic groups traditionally excluded in academic medicine and biomedical research, and who wish to conduct original breast cancer research not currently funded.

Letter of Intent Due: December 14, 2021


These represent an effort to encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to cancer disparities.

Application Deadline: January 7, 2022


Designed with the primary goal of increasing diversity in the oncology workforce and cancer research. This CDA will provide funding to clinical investigators who have received their initial faculty appointment and identify as members of racial and/or ethnic groups traditionally excluded in academic medicine and biomedical research.

Application Deadline: January 10, 2022


Provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment.

Application Deadline: January 10, 2022


The intent of this program is to increase diversity in clinical trials. The initiative is comprised of a Career Development Program for early-stage clinical investigators and a Clinical Investigator Pipeline Program (BMSF CIPP) for rising second-year medical students.

Application Deadline: January 14, 2022


This NOSI to encourage research studies designed to identify and understand the mechanisms by which biologic factors (microbial, immune, genetic) contribute to disparities in dental, oral, and craniofacial disease onset, progression, and persistence.

Application Deadline: February 5, 2022


The Society for Immunotherapy of Cancer’s (SITC) fourth annual Cancer Immunotherapy Winter School, Jan. 24–28, 2022, will be offered in a hybrid format with opportunities to participate in Austin, TX and virtually! We are proud to present the best in cancer immunotherapy education taught by leading experts in the field, whether you plan to travel or attend remotely. This program provides all attendees with a deep understanding of the core principles of tumor immunology and cancer immunotherapy and examines developing areas in the field


Search all available funding opportunities and how to apply.